Ensign Peak Advisors, Inc Keros Therapeutics, Inc. Transaction History
Ensign Peak Advisors, Inc
- $54.2 Billion
- Q2 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 71,740 shares of KROS stock, worth $4.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71,740
Previous 71,740
-0.0%
Holding current value
$4.05 Million
Previous $4.75 Million
30.97%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
157Shares Held
27.1MCall Options Held
28.7KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$99.2 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$90.3 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$86.1 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$71.6 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.45B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...